Trial · NCT07881796
Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver Disease
NCT07881796, Not applicable, Completed, Shalamar Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver Disease. Trials, record NCT07881796. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881796
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver Disease
- NCT number
- NCT07881796
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 146 participants, actual
- Lead sponsor
- Shalamar Hospital
- Conditions
- Non-Alcoholic Fatty Liver Disease
- Interventions
- Dapagliflozin (10mg Tab), Placebo
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Body Mass Index | Baseline and 12 weeks | Mean change in body mass index, expressed in kg/m², compared between the dapagliflozin and placebo groups. Body mass index is calculated as weight in kilograms divided by height in metres squared. Weight is measured using a standardized digital weighing scale, and height is measured using a stadiometer. |
| Secondary | Change in Body Weight | Baseline and 12 weeks | Mean change in body weight, expressed in kilograms, compared between the treatment groups. Weight is measured using a standardized digital weighing scale with participants wearing light clothing and no shoes. |
| Secondary | Change in Fasting Blood Glucose | Baseline and 12 weeks | Mean change in fasting blood glucose, expressed in mg/dL, compared between the treatment groups. Glucose is measured using a standardized glucose meter after an overnight fast of at least eight hours. |
| Secondary | Change in Glycated Hemoglobin | Baseline and 12 weeks | Mean change in glycated hemoglobin, expressed in percentage points, compared between the treatment groups. Glycated hemoglobin is measured using high-performance liquid chromatography. |
| Secondary | Change in Serum Total Cholesterol | Baseline and 12 weeks | Mean change in serum total cholesterol, expressed in mg/dL, compared between the treatment groups. Serum levels are measured using an automated biochemical analyzer. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881796
GET https://conductscience.org/api/trials/v1/NCT07881796/registered